The world’s Largest Sharp Brain Virtual Experts Marketplace Just a click Away
Levels Tought:
Elementary,Middle School,High School,College,University,PHD
| Teaching Since: | May 2017 |
| Last Sign in: | 402 Weeks Ago, 3 Days Ago |
| Questions Answered: | 66690 |
| Tutorials Posted: | 66688 |
MCS,PHD
Argosy University/ Phoniex University/
Nov-2005 - Oct-2011
Professor
Phoniex University
Oct-2001 - Nov-2016
Equity method; adjustment for depreciation
Fizer Pharmaceutical paid $68 million on January 2, 2016, for 4 million shares of Carne Cosmetics common stock. The investment represents a 25% interest in the net assets of Carne and gave Fizer the ability to exercise significant influence over Carne’s operations. Fizer received dividends of $1 per share on December 21, 2016, and Carne reported net income of $40 million for the year ended December 31, 2016. The fair value of Carne’s common stock at December 31, 2016, was $18.50 per share.
• The book value of Carne’s net assets was $192 million.
• The fair value of Carne’s depreciable assets exceeded their book value by $32 million. These assets had an average remaining useful life of eight years.
• The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill.
Required:
Prepare all appropriate journal entries related to the investment during 2016.
Hel-----------lo -----------Sir-----------/Ma-----------dam-----------Tha-----------nk -----------You----------- fo-----------r u-----------sin-----------g o-----------ur -----------web-----------sit-----------e a-----------nd -----------and----------- ac-----------qui-----------sit-----------ion----------- of----------- my----------- po-----------ste-----------d s-----------olu-----------tio-----------n.P-----------lea-----------se -----------pin-----------g m-----------e o-----------n c-----------hat----------- I -----------am -----------onl-----------ine----------- or----------- in-----------box----------- me----------- a -----------mes-----------sag-----------e I----------- wi-----------ll